Publikationen, an denen er mitarbeitet Enrique José Andreu Oltra (11)

2023

  1. Enhanced bioprocess control to advance the manufacture of mesenchymal stromal cell-derived extracellular vesicles in stirred-tank bioreactors

    Biotechnology and Bioengineering, Vol. 120, Núm. 9, pp. 2725-2741

2021

  1. Preclinical evaluation of the safety and immunological action of allogeneic ADSC-collagen scaffolds in the treatment of chronic ischemic cardiomyopathy

    Pharmaceutics, Vol. 13, Núm. 8

2011

  1. MAPC transplantation confers a more durable benefit than AC133+ cell transplantation in severe hind limb ischemia

    Cell Transplantation, Vol. 20, Núm. 2, pp. 259-269

2008

  1. BCR-ABL1-induced expression of HSPA8 promotes cell survival in chronic myeloid leukaemia

    British Journal of Haematology, Vol. 142, Núm. 4, pp. 571-582

  2. Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium

    European Journal of Heart Failure, Vol. 10, Núm. 11, pp. 1065-1072

  3. Resistance to Imatinib Mesylate-induced apoptosis in acute lymphoblastic leukemia is associated with PTEN down-regulation due to promoter hypermethylation

    Leukemia Research, Vol. 32, Núm. 5, pp. 709-716

2007

  1. In vitro and in vivo arterial differentiation of human multipotent adult progenitor cells

    Blood, Vol. 109, Núm. 6, pp. 2634-2642

2006

  1. Can bone marrow-derived multipotent adult progenitor cells regenerate infarcted myocardium?

    Cardiovascular Research, Vol. 72, Núm. 1, pp. 175-183

2005

  1. Coexistence of different clonal populations harboring the b3a2 (p210) and e1a2 (p190) BCR-ABL1 fusion transcripts in chronic myelogenous leukemia resistant to imatinib

    Cancer Genetics and Cytogenetics, Vol. 160, Núm. 1, pp. 22-26

2004

  1. NALP1 is a transcriptional target for cAMP-response-element-binding protein (CREB) in myeloid leukaemia cells

    Biochemical Journal, Vol. 384, Núm. 2, pp. 281-286

2003

  1. Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response

    Haematologica, Vol. 88, Núm. 12, pp. 1425-1426